11 research outputs found

    Triterpenoids from the fruits and leaves of the blackberry (<i>Rubus allegheniensis</i>) and their inhibitory activities on foam cell formation in human monocyte-derived macrophage

    No full text
    <div><p>From the methanol extract of the fruits of the blackberry (<i>Rubus allegheniensis</i> Port.), four triterpenoids – pomolic acid (<b>1</b>), tormentic acid (<b>2</b>), euscaphic acid (<b>3</b>) and 1β-hydroxyeuscaphic acid (<b>4</b>) – were isolated, while six triterpenoids – <b>2</b>, <b>3</b>, myrianthic acid (<b>5</b>), ziyu glycoside II (<b>6</b>), sericic acid (<b>7</b>) and 19-hydroxy-2,3-secours-12-ene-2,3,28-trioic acid 3-methyl ester (<b>8</b>) – were obtained from the methanol extract of the leaves of this plant. Their structures were determined on the basis of spectral data. Compounds <b>1</b>–<b>8</b> were examined for their inhibitory activities on foam cell formation in human monocyte-derived macrophages induced by acetylated low-density lipoproteins at a 50 μM concentration. Among the tested compounds, <b>1</b> showed the strongest activity, with the inhibitory effect being 90%. The inhibitory activities of <b>2</b>–<b>8</b> were evaluated to be 30%, 32%, 33%, 4%, 48%, 4% and 24%, respectively. Further, the structure–activity relationship of these compounds was investigated.</p></div

    Tomatidine, a Tomato Sapogenol, Ameliorates Hyperlipidemia and Atherosclerosis in ApoE-Deficient Mice by Inhibiting Acyl-CoA:cholesterol Acyl-transferase (ACAT)

    No full text
    It was previously revealed that esculeoside A, a new glycoalkaloid, and esculeogenin A, a new aglycon of esculeoside A, contained in ripe tomato ameliorate atherosclerosis in apoE-deficent mice. This study examined whether tomatidine, the aglycone of tomatine, which is a major tomato glycoalkaloid, also shows similar inhibitory effects on cholesterol ester (CE) accumulation in human monocyte-derived macrophages (HMDM) and atherogenesis in apoE-deficient mice. Tomatidine significantly inhibited the CE accumulation induced by acetylated LDL in HMDM in a dose-dependent manner. Tomatidine also inhibited CE formation in Chinese hamster ovary cells overexpressing acyl-CoA:cholesterol acyl-transferase (ACAT)-1 or ACAT-2, suggesting that tomatidine suppresses both ACAT-1 and ACAT-2 activities. Furthermore, the oral administration of tomatidine to apoE-deficient mice significantly reduced levels of serum cholesterol, LDL-cholesterol, and areas of atherosclerotic lesions. The study provides the first evidence that tomatidine significantly suppresses the activity of ACAT and leads to reduction of atherogenesis

    Tomatidine, a Tomato Sapogenol, Ameliorates Hyperlipidemia and Atherosclerosis in ApoE-Deficient Mice by Inhibiting Acyl-CoA:cholesterol Acyl-transferase (ACAT)

    No full text
    It was previously revealed that esculeoside A, a new glycoalkaloid, and esculeogenin A, a new aglycon of esculeoside A, contained in ripe tomato ameliorate atherosclerosis in apoE-deficent mice. This study examined whether tomatidine, the aglycone of tomatine, which is a major tomato glycoalkaloid, also shows similar inhibitory effects on cholesterol ester (CE) accumulation in human monocyte-derived macrophages (HMDM) and atherogenesis in apoE-deficient mice. Tomatidine significantly inhibited the CE accumulation induced by acetylated LDL in HMDM in a dose-dependent manner. Tomatidine also inhibited CE formation in Chinese hamster ovary cells overexpressing acyl-CoA:cholesterol acyl-transferase (ACAT)-1 or ACAT-2, suggesting that tomatidine suppresses both ACAT-1 and ACAT-2 activities. Furthermore, the oral administration of tomatidine to apoE-deficient mice significantly reduced levels of serum cholesterol, LDL-cholesterol, and areas of atherosclerotic lesions. The study provides the first evidence that tomatidine significantly suppresses the activity of ACAT and leads to reduction of atherogenesis

    Measurement of anti-oxidative effects of LVFX using EPR spectroscopy.

    No full text
    <p>The scavenging activities of LVFX against ROS derived from the UV/H<sub>2</sub>O<sub>2</sub> system or neutrophils stimulated with 100 ng/ml PMA were determined using ESR spin trapping with DMPO. (A) The reaction mixtures, which contained 500 μM H<sub>2</sub>O<sub>2</sub>, 100 μM DTPA and 4.5 mM DMPO, were incubated with each FQ and were immediately transferred to an ESR flat cell and irradiated at 254 nm for 30 s. After UV-irradiation, the ESR flat cells immediately placed in a JES-TE 200 ESR spectrometer. ESR spectrum of DMPO spin adducts of OH radicals and (B) the quantitation of the OH radicals concentration were shown. (C) The scavenging activity of 200 μM FQs; lomefloxacin (LFLX), levofloxacin (LVFX), Ciprofloxacin (CPFX), pazfloxacin (PZFX), and norfloxacin (NRFX) against OH radicals. (D) ESR spectrum of DMPO spin adducts ROS derived from neutrophils containing OH radicals, and (E) the quantitation of the ROS concentration were shown. Each bar represents the mean ± SD (n = 3). *p<0.05, **p<0.01 vs control.</p

    The effect of LVFX on oxidative stress in influenza virus-infected mice.

    No full text
    <p>The effect of LVFX on the accumulation of oxidative stress in the blood or lungs were determined (A) by measuring hydroperoxide levels (dROMs test) or (B) immunostaining for 8-OHdG (upper panel) and NO<sub>2</sub>-Tyr (lower panel) level at the day 7 after influenza virus infection. The fluorescence intensity of (C) 8-OHdG and (D) NO<sub>2</sub>-Tyr were quantified by the imageJ software. Each bar represents the mean ± SD (n = 5–9). **p<0.01, ***p<0.001 vs control.</p

    The effect of LVFX on lung damage and viral titer in influenza virus-infected mice.

    No full text
    <p>(A) Section of lung tissue were prepared at the day 7 after influenza virus infection, and subjected to histopathological examination with HE staining (upper). The alveolar space was observed in lungs from control mice, however the influenza virus infection caused a marked increase in the infiltration of inflammatory cells into the alveoli or peribronchial areas, and the alveolar space was completely filled with these cells. Treatment with LVFX at a dose of 100 mg/kg decreased the overall infiltration of inflammatory cells. The histopathological severity of lung section was determined and average score showed in lower of HE staining image. Histological score shown PBS (n = 4), 25 mg/kg LVFX (n = 5) and 100 mg/kg LVFX (n = 5). (B) The effect of LVFX on viral load at day 4 and 7 were determined using a plaque forming assay. Each bar represents the mean ± SD (n = 3–5). *p<0.05, **p<0.01 vs PBS.</p

    Acanthomanzamines A–E with New Manzamine Frameworks from the Marine Sponge <i>Acanthostrongylophora ingens</i>

    No full text
    Five new manzamine alkaloids, acanthomanzamines A–E, were isolated from the marine sponge <i>Acanthostrongylophora ingens</i>. Acanthomanzamines A and B are the first examples, containing a tetrahydroisoquinoline instead of a β-carboline in manzamine-related alkaloids. Acanthomanzamine C contains a hexahydrocyclopenta­[<i>b</i>]­pyrrol-4­(2<i>H</i>)-one ring that may be converted from an eight-membered ring in manzamine A. Acanthomanzamines D and E have an additional oxazolidine and 2-methyloxazolidine rings, respectively, which fuse to the manzamine skeleton

    The effect of LVFX on NO and IFN-γ production in BALF of influenza virus-infected mice.

    No full text
    <p>(A) The effect of LVFX on the accumulation of NO in BALF was determined by measuring NOx (NO<sub>2</sub><sup>-</sup> and NO<sub>3</sub><sup>-</sup>). (B) IFN-γ levels in the BALF were determined by ELISA on day 7 after influenza virus administration. Each bar represents the mean ± SD (n = 4–5). *p<0.05, **p<0.01 vs control.</p

    Therapeutic effect of LVFX on influenza virus-infected mice.

    No full text
    <p>Influenza virus infected mice were produced by the intratracheal administration of influenza virus under anesthesia on day 0. After infection, the mice were treated with LVFX on day 2 after infection by means of an intraperitoneal injection of LVFX. (A) Survival curves for control (n = 3), 100 mg/kg LVFX (not infected, n = 3), PBS (n = 10), 25 mg/kg LVFX (n = 10) and 100 mg/kg LVFX (n = 10) treatment during an influenza virus infection. (B) Weight loss during an influenza virus infection. Each bar represents the mean ± SD. **p<0.01 vs vehicle. Experiment was repeated three times.</p
    corecore